PROGNOSTIC VALUE OF CYTOKERATINS AND CARCINOEMBRYONIC ANTIGEN EXPRESSION IN PRIMARY SURGICALLY TREATED CERVICAL-CANCER

被引:0
作者
KAINZ, C
ZEISLER, H
KOHLBERGER, P
GITSCH, G
HEINZL, H
BREITENECKER, G
REINTHALLER, A
机构
[1] UNIV VIENNA, DEPT MED COMP SCI, VIENNA, AUSTRIA
[2] UNIV VIENNA, INST PATHOL, GYNECOPATHOL UNIT, VIENNA, AUSTRIA
关键词
CYTOKERATINS; CARCINOEMBRYONIC ANTIGEN; CERVICAL CANCER; WERTHEIM-MEIGS OPERATION; PROGNOSIS;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In a previous study we have shown the prognostic value of expression of cytokeratins and carcinoembryonic antigen (CEA) in cervical cancer FIGO stage III. The present study was performed to evaluate the prognostic value of cytokeratins and CEA in patients with cervical primary cancer stage IB to IIB, surgically treated by radical hysterectomy and lymphadenectomy. Seventy-six patients were included in the study. By application of immunohistochemistry we found AE1/AE3 (cytokeratins) expression in 27 (35.5%) cases and CEA expression in 56 (73.7%) cases. Multivariate analysis for the end points of relapse-free survival and overall survival showed that neither AE1/AE3 expression nor CEA expression had a prognostic value in the studied population. In contrast to patients with primary irradiated cervical carcinoma FIGO stage III, patients with primary surgically treated tumors stage IB to IIB showed no significant prognostic value of cytokeratin or CEA expression of the tumor.
引用
收藏
页码:667 / 671
页数:5
相关论文
共 20 条
[1]   IDENTIFICATION OF PROGNOSTIC FACTORS AND RISK GROUPS IN PATIENTS FOUND TO HAVE NODAL METASTASIS AT THE TIME OF RADICAL HYSTERECTOMY FOR EARLY-STAGE SQUAMOUS CARCINOMA OF THE CERVIX [J].
ALVAREZ, RD ;
SOONG, SJ ;
KINNEY, WK ;
REID, GC ;
SCHRAY, MF ;
PODRATZ, KC ;
MORLEY, GW ;
SHINGLETON, HM .
GYNECOLOGIC ONCOLOGY, 1989, 35 (02) :130-135
[2]   HISTOLOGICAL CRITERIA FOR THE PROGNOSIS IN PATIENTS WITH OPERATED SQUAMOUS-CELL CARCINOMA OF THE CERVIX [J].
BALTZER, J ;
LOHE, KJ ;
KOPCKE, W ;
ZANDER, J .
GYNECOLOGIC ONCOLOGY, 1982, 13 (02) :184-194
[3]   TUMOR SIZE AND LYMPH-NODE METASTASES IN SQUAMOUS-CELL CARCINOMA OF THE UTERINE CERVIX [J].
BALTZER, J ;
KOEPCKE, W .
ARCHIVES OF GYNECOLOGY, 1979, 227 (03) :271-278
[4]   ASSESSMENT OF PROGNOSTIC CRITERIA IN UTERINE CARCINOMAS [J].
BALTZER, J .
GEBURTSHILFE UND FRAUENHEILKUNDE, 1981, 41 (10) :663-667
[5]   THE SIGNIFICANCE OF MICROSCOPIC INVOLVEMENT OF THE PARAMETRIUM AND OR PELVIC LYMPH-NODES IN CERVICAL-CANCER STAGE-IB AND STAGE-IIA [J].
BLEKER, OP ;
KETTING, BW ;
VANWAYJENEECEN, B ;
KLOOSTERMAN, GJ .
GYNECOLOGIC ONCOLOGY, 1983, 16 (01) :56-62
[6]   PROGNOSTIC FACTORS AND OPERATIVE TREATMENT OF STAGE-IB TO STAGE-IIB CERVICAL-CANCER [J].
BURGHARDT, E ;
PICKEL, H ;
HAAS, J ;
LAHOUSEN, M .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1987, 156 (04) :988-996
[7]  
COX DR, 1972, J R STAT SOC B, V34, P187
[8]   HISTOPATHOLOGIC PROGNOSTIC FACTORS IN STAGE-II AND STAGE-III SQUAMOUS-CELL CARCINOMA OF THE UTERINE CERVIX - AN EVALUATION OF 91 PATIENTS TREATED PRIMARILY WITH RADIATION-THERAPY [J].
CRISSMAN, JD ;
BUDHRAJA, M ;
ARON, BS ;
CUMMINGS, G .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 1987, 6 (02) :97-103
[9]   IMMUNOHISTOCHEMICAL STUDIES ON UTERINE-TUMORS .1. INVASIVE SQUAMOUS-CELL CARCINOMAS OF THE CERVIX AND THEIR PRECURSORS [J].
DALLENBACHHELLWEG, G ;
LANG, G .
PATHOLOGY RESEARCH AND PRACTICE, 1991, 187 (01) :36-43
[10]  
EIDE TJ, 1987, J NATL CANCER I, V79, P199